New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 28, 2012
10:00 EDTREN, UTI, SDRL, FRED, TFM, VIVO, WIN, RDC, ESV, VRTX, BRY, SHW, RAH, CTLOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: CenturyLink (CTL) downgraded to Neutral from Overweight at Piper Jaffray... Ensco (ESV) downgraded to Hold from Buy at Deutsche Bank... Fred's (FRED) downgraded to Neutral from Buy at SunTrust... Ralcorp (RAH) downgraded to Neutral from Buy at UBS... Rowan Companies (RDC) downgraded to Hold from Buy at Deutsche Bank... Seadrill (SDRL) downgraded to Hold from Buy at Deutsche Bank... Sherwin-Williams (SHW) downgraded to Neutral from Buy at Nomura... Windstream (WIN) downgraded to Underweight from Neutral at Piper Jaffray... Universal Technical (UTI) downgraded to Underperform from Market Perform at BMO... Barry Petroleum (BRY) downgraded to Market Perform from Outperform at BMO Capital... Meridian Bioscience (VIVO) downgraded to Underperform from Neutral at Wedbush... Resolute Energy (REN) downgraded to Market Perform from Outperform at BMO Capital... Vertex (VRTX) downgraded to Hold from Buy at Argus... The Fresh Market (TFM) downgraded to Hold from Buy at Deutsche Bank.
News For CTL;ESV;FRED;RAH;RDC;SDRL;SHW;WIN;UTI;BRY;VIVO;REN;VRTX;TFM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
August 20, 2015
16:18 EDTTFMThe Fresh Market cites YTD results, current environment for lowered outlook
Interim CEO Crane concluded, "We believe that our strategic initiatives will better position The Fresh Market to compete long-term. We remain focused on evolving our operating model to provide customers with a unique and differentiated grocery shopping experience, although we expect that it will take time to fully realize the benefits of our efforts. Based on year to date results and the current operating environment, we are lowering our previously issued sales and earnings guidance for fiscal 2015."
16:17 EDTTFMThe Fresh Market lowers FY15 adjusted EPS view to $1.55-$1.65 from $1.85-$1.93
FY15 consensus $1.85. Management's outlook for the 53-week fiscal 2015 is based upon the following expectations: Total net sales growth for the 53-week fiscal 2015 of approximately 5.0%-7.0% compared to the 52-week fiscal 2014 total net sales. Fiscal 2014 included the benefit of sales from the Company's three California stores prior to their closing; Comparable store sales for the first 52 weeks of fiscal 2015 of -1.0% to -2.5%; An effective tax rate of 37.0% to 37.3%; Approximately $95M-$105M in capital expenditures, primarily related to real estate investments; Unit growth of approximately 18 new stores; Remodeling or refreshing 9 to 10 stores; Approximately 8c per diluted share of earnings related to the 53rd week of operations in the fourth quarter of fiscal 2015.
16:17 EDTTFMThe Fresh Market hits a fresh life low after results
Subscribe for More Information
16:15 EDTTFMThe Fresh Market lowers FY15 outlook
Subscribe for More Information
16:14 EDTTFMThe Fresh Market announces $200M stock repurchase program
16:13 EDTTFMThe Fresh Market reports Q2 adjusted EPS 36c, consensus 40c
Subscribe for More Information
15:56 EDTWINWindstream said to hire RBC to explore sale of data storage business
Subscribe for More Information
14:42 EDTTFMNotable companies reporting after market close
Subscribe for More Information
14:05 EDTWINWindstream said to hire RBC to explore sale of data storage business
Subscribe for More Information
10:00 EDTTFMOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:08 EDTTFMThe Fresh Market downgraded to Underperform at BofA/Merrill
Subscribe for More Information
07:37 EDTTFMThe Fresh Market downgraded to Underperform from Neutral at BofA/Merrill
07:10 EDTTFMThe Fresh Market price target lowered to $30 from $34 at RBC Capital
RBC Capital analyst William Kirk lowered his price target for The Fresh Market to $30 after reducing his comparable store estimate for the quarter to 0.0%. The company is not immune from the decelerating trends reported by peers, Kirk tells investors in a research note. He reiterates an Underperform rating on The Fresh Market.
August 18, 2015
10:00 EDTSHWOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:08 EDTSHWSherwin-Williams upgraded to Neutral from Sell at UBS
UBS analyst John Roberts upgraded Sherwin-Williams to Neutral citing the relative underperformance of shares. The stock is high quality and "difficult to be bearish on," Roberts tells investors in a research note. He raised his price target for shares to $284 from $278.
August 17, 2015
10:09 EDTTFMOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:30 EDTTFMThe Fresh Market downgraded on negative comps risk at BMO Capital
Subscribe for More Information
07:46 EDTRENEnerCom to hold a conference
Subscribe for More Information
06:54 EDTTFMThe Fresh Market downgraded to Market Perform from Outperform at BMO Capital
Subscribe for More Information
06:22 EDTVRTXPiper's Tenthoff sees select biotech names outperforming in second half
Piper Jaffray analyst Edward Tenthoff expects drug launches, clinical data read-outs and potential partnerships to drive outperformance for select biotech names in the second half of 2015. Despite some recent profit-taking, 2015 has been another strong year for biotech stocks, Tenthoff tells investors in a research note. Names with important second half of the year catalysts include Vertex (VRTX), Regeneron (REGN), Seattle Genetics (SGEN), Exelixis (EXEL), Sarepta (SRPT), Novavax (NVAX), Arrowhead (ARWR), Array BioPharma (ARRY), Alnylam (ALNY), Genocea (GNCA), CymaBay (CBAY), Idera Pharmaceuticals (IDRA), Vitae Pharmaceuticals (VTAE).
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use